# Population Genetics Technologies

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/population-genetics-technologies

- Industry: Biotechnology
- Headquarters: Cambridge, UK
- Website: www.popgentech.com
- Total disclosed funding: $14M
- Latest round: Series G (Mar 28, 2013)
- Investors on record: 6

## About

Population Genetics Technologies provides innovative technology solutions focused on data analytics, integration, and visualization, catering to various industries including healthcare, finance, and retail.Population Genetics Technologies specializes in advanced analytics and data management solutions. The company is headquartered in Cambridge, UK. It has received funding through a Series G round from Auriga Partners, raising GBP 0.30 mn, bringing the total amount raised to GBP 0.30 mn and valuing the company at GBP 14.688 mn. The firm has completed 8 deals to date.Population Genetics Technologies specializes in innovative technology solutions designed to address key challenges in various industries. The company's core product offerings include advanced analytics software, data visualization tools, and cloud-based platforms that facilitate seamless data integration and management. These solutions empower businesses to harness their data more effectively, leading to improved decision-making processes and operational efficiencies. The end use cases primarily revolve around enhancing productivity, guiding strategic initiatives, and providing insights that drive competitive advantage. Population Genetics Technologies’ customer base spans multiple sectors, including healthcare, finance, and retail, with clients located in North America, Europe, and Asia-Pacific, showcasing the company's global market reach.Population Genetics Technologies generates revenue through a subscription-based model, providing clients access to its suite of software products and services. In 2018, the company's revenue was GBP 233,733.10, with an EBITDA of GBP -177,020.50. Clients typically enter into annual contracts, which include tiered pricing structures based on the number of users and the level of service required. Flagship products, such as their analytics software, are offered at distinct pricing tiers, allowing organizations of varying sizes to benefit from their technology. In addition to subscriptions, Population Genetics Technologies may also engage in partnerships with other tech firms to expand its product offerings and enhance value through collaborative solutions. This revenue structure supports continuous innovation and service improvements, reinforcing the company’s position in the technology landscape.Population Genetics Technologies is focused on developing new products to enhance its analytics and data visualization offerings, with plans to launch updates in the upcoming year. The company aims to expand its market presence in North America and Asia-Pacific by the end of 2024. The recent funding from the Series G round will be utilized to support these initiatives, ensuring the company can enhance its product development and market penetration strategies.

## Funding rounds

- Series G, Mar 28, 2013, $0.5M — Auriga Partners
- Series F, Sep 26, 2012, $1.6M — Auriga Partners
- Series B, Oct 3, 2011, $5.7M — Auriga Partners, Beringea, The Welcom Trust, Compass Genetics Investors LLC, Syngenta Ventures
- Series A, Feb 15, 2008, $6.3M — Auriga Partners, Noble Fund Management, Compass Genetics Investors LLC

## Investors

- Auriga Partners (https://capitalatlas.ai/funds/auriga-partners) — Series A, Series B, Series F, Series G
- Noble Fund Management (https://capitalatlas.ai/funds/noble-fund-management) — Series A
- Compass Genetics Investors LLC — Series A, Series B
- Beringea (https://capitalatlas.ai/funds/beringea) — Series B
- The Welcom Trust — Series B
- Syngenta Ventures (https://capitalatlas.ai/funds/syngenta-ventures) — Series B